Onc File published (year): 2023
Oncoinvent would like to extend an invitation to a short update on the company. The presentation will be held on Friday 17. February 2023 at 09:00 AM in the company offices at Gullhaugsveien 7, Oslo, 3rd Floor. It will also be possible to attend virtually. To attend, please register with firstname.lastname@example.org. ————————————————– Oncoinvent ønsker med … Read more
Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced strong progress with clinical trials, including patient recruitment and efficacy signals. Further updates will be provided in an upcoming investor conference call.